S&P 500   3,992.80 (+0.55%)
DOW   32,452.89 (+0.67%)
QQQ   311.17 (+0.09%)
AAPL   160.40 (+0.09%)
MSFT   280.42 (-0.05%)
META   204.95 (-0.51%)
GOOGL   104.66 (-0.74%)
AMZN   99.01 (+0.90%)
TSLA   197.11 (+3.52%)
NVDA   269.35 (+0.58%)
NIO   9.07 (+0.00%)
BABA   87.17 (+0.31%)
AMD   98.38 (+0.44%)
T   18.80 (+1.02%)
F   11.58 (+0.61%)
MU   61.14 (-0.03%)
CGC   1.91 (+0.41%)
GE   93.05 (+1.84%)
DIS   95.19 (+1.18%)
AMC   4.44 (-0.67%)
PFE   40.16 (-0.57%)
PYPL   74.78 (+1.22%)
NFLX   331.68 (+1.00%)
S&P 500   3,992.80 (+0.55%)
DOW   32,452.89 (+0.67%)
QQQ   311.17 (+0.09%)
AAPL   160.40 (+0.09%)
MSFT   280.42 (-0.05%)
META   204.95 (-0.51%)
GOOGL   104.66 (-0.74%)
AMZN   99.01 (+0.90%)
TSLA   197.11 (+3.52%)
NVDA   269.35 (+0.58%)
NIO   9.07 (+0.00%)
BABA   87.17 (+0.31%)
AMD   98.38 (+0.44%)
T   18.80 (+1.02%)
F   11.58 (+0.61%)
MU   61.14 (-0.03%)
CGC   1.91 (+0.41%)
GE   93.05 (+1.84%)
DIS   95.19 (+1.18%)
AMC   4.44 (-0.67%)
PFE   40.16 (-0.57%)
PYPL   74.78 (+1.22%)
NFLX   331.68 (+1.00%)
S&P 500   3,992.80 (+0.55%)
DOW   32,452.89 (+0.67%)
QQQ   311.17 (+0.09%)
AAPL   160.40 (+0.09%)
MSFT   280.42 (-0.05%)
META   204.95 (-0.51%)
GOOGL   104.66 (-0.74%)
AMZN   99.01 (+0.90%)
TSLA   197.11 (+3.52%)
NVDA   269.35 (+0.58%)
NIO   9.07 (+0.00%)
BABA   87.17 (+0.31%)
AMD   98.38 (+0.44%)
T   18.80 (+1.02%)
F   11.58 (+0.61%)
MU   61.14 (-0.03%)
CGC   1.91 (+0.41%)
GE   93.05 (+1.84%)
DIS   95.19 (+1.18%)
AMC   4.44 (-0.67%)
PFE   40.16 (-0.57%)
PYPL   74.78 (+1.22%)
NFLX   331.68 (+1.00%)
S&P 500   3,992.80 (+0.55%)
DOW   32,452.89 (+0.67%)
QQQ   311.17 (+0.09%)
AAPL   160.40 (+0.09%)
MSFT   280.42 (-0.05%)
META   204.95 (-0.51%)
GOOGL   104.66 (-0.74%)
AMZN   99.01 (+0.90%)
TSLA   197.11 (+3.52%)
NVDA   269.35 (+0.58%)
NIO   9.07 (+0.00%)
BABA   87.17 (+0.31%)
AMD   98.38 (+0.44%)
T   18.80 (+1.02%)
F   11.58 (+0.61%)
MU   61.14 (-0.03%)
CGC   1.91 (+0.41%)
GE   93.05 (+1.84%)
DIS   95.19 (+1.18%)
AMC   4.44 (-0.67%)
PFE   40.16 (-0.57%)
PYPL   74.78 (+1.22%)
NFLX   331.68 (+1.00%)

ICU Medical - ICUI Stock Forecast, Price & News

$157.86
+1.63 (+1.04%)
(As of 03/27/2023 09:40 AM ET)
Add
Compare
Today's Range
$157.74
$159.43
50-Day Range
$153.15
$198.21
52-Week Range
$128.90
$233.88
Volume
5,780 shs
Average Volume
186,779 shs
Market Capitalization
$3.79 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$195.00

ICU Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
24.8% Upside
$195.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-1.47
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$346,200 Sold Last Quarter
Proj. Earnings Growth
35.51%
From $5.21 to $7.06 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.24 out of 5 stars

Medical Sector

358th out of 995 stocks

Surgical & Medical Instruments Industry

31st out of 103 stocks


ICUI stock logo

About ICU Medical (NASDAQ:ICUI) Stock

ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

Receive ICUI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter.

ICUI Stock News Headlines

My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
Q4 2022 ICU Medical Inc Earnings Call
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
ICU Medical (ICUI) Beats Q4 Earnings Estimates
ICU Medical Stock Hits New 52-Week High (ICUI)
ICU Medical's Earnings: A Preview
ICU Medical
U.S. FDA warns of tracheostomy tube shortage
See More Headlines
Receive ICUI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter.

ICUI Company Calendar

Last Earnings
11/03/2021
Today
3/27/2023
Next Earnings (Estimated)
5/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ICUI
CUSIP
44930G10
Employees
14,500
Year Founded
1984

Price Target and Rating

Average Stock Price Forecast
$195.00
High Stock Price Forecast
$200.00
Low Stock Price Forecast
$190.00
Forecasted Upside/Downside
+24.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-74,290,000.00
Pretax Margin
-5.02%

Debt

Sales & Book Value

Annual Sales
$2.28 billion
Cash Flow
$16.74 per share
Book Value
$87.15 per share

Miscellaneous

Free Float
22,246,000
Market Cap
$3.75 billion
Optionable
Optionable
Beta
0.61

Social Links


Key Executives

  • Vivek JainVivek Jain
    Chairman & Chief Executive Officer
  • Christian B. Voigtlander
    Chief Operating Officer
  • Brian M. Bonnell
    Chief Financial Officer & Treasurer
  • Krishna Uppugonduri
    VP-Quality, Medical & Regulatory Affairs
  • Virginia SanzoneVirginia Sanzone
    Secretary, Vice President & General Counsel













ICUI Stock - Frequently Asked Questions

Should I buy or sell ICU Medical stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ICUI shares.
View ICUI analyst ratings
or view top-rated stocks.

What is ICU Medical's stock price forecast for 2023?

2 brokerages have issued 1 year price objectives for ICU Medical's stock. Their ICUI share price forecasts range from $190.00 to $200.00. On average, they predict the company's share price to reach $195.00 in the next year. This suggests a possible upside of 24.8% from the stock's current price.
View analysts price targets for ICUI
or view top-rated stocks among Wall Street analysts.

How have ICUI shares performed in 2023?

ICU Medical's stock was trading at $157.48 at the start of the year. Since then, ICUI stock has decreased by 0.8% and is now trading at $156.23.
View the best growth stocks for 2023 here
.

When is ICU Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023.
View our ICUI earnings forecast
.

How were ICU Medical's earnings last quarter?

ICU Medical, Inc. (NASDAQ:ICUI) issued its earnings results on Wednesday, November, 3rd. The medical instruments supplier reported $2.07 earnings per share for the quarter, topping analysts' consensus estimates of $1.57 by $0.50. The medical instruments supplier had revenue of $336.06 million for the quarter, compared to analysts' expectations of $314.20 million. ICU Medical had a negative net margin of 3.26% and a positive trailing twelve-month return on equity of 6.15%. During the same quarter in the previous year, the company earned $1.61 earnings per share.

What guidance has ICU Medical issued on next quarter's earnings?

ICU Medical updated its FY 2023 earnings guidance on Monday, February, 27th. The company provided EPS guidance of $5.75-$7.25 for the period, compared to the consensus EPS estimate of $1.29. The company issued revenue guidance of -.

What is Vivek Jain's approval rating as ICU Medical's CEO?

81 employees have rated ICU Medical Chief Executive Officer Vivek Jain on Glassdoor.com. Vivek Jain has an approval rating of 73% among the company's employees.

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), CA (CA), UnitedHealth Group (UNH), Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW).

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include T. Rowe Price Investment Management Inc. (10.10%), Nuance Investments LLC (3.92%), JPMorgan Chase & Co. (3.15%), Morgan Stanley (2.84%), Fuller & Thaler Asset Management Inc. (2.41%) and Neuberger Berman Group LLC (1.85%). Insiders that own company stock include Daniel Woolson, Elisha W Finney, George A Lopez, Robert S Swinney, Virginia Ruth Sanzone and Vivek Jain.
View institutional ownership trends
.

How do I buy shares of ICU Medical?

Shares of ICUI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $156.23.

How much money does ICU Medical make?

ICU Medical (NASDAQ:ICUI) has a market capitalization of $3.75 billion and generates $2.28 billion in revenue each year. The medical instruments supplier earns $-74,290,000.00 in net income (profit) each year or ($3.12) on an earnings per share basis.

How many employees does ICU Medical have?

The company employs 14,500 workers across the globe.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The official website for the company is www.icumed.com. The medical instruments supplier can be reached via phone at (949) 366-2183, via email at ir@icumed.com, or via fax at 949-366-8368.

This page (NASDAQ:ICUI) was last updated on 3/27/2023 by MarketBeat.com Staff